The Centralized List annual renewal application and fee must be submitted to DOJ by January 31st of each year regardless of the date of initial placement on the Centralized List. The Centralized List portion of the annual fee is $20.00 per licensee at each dealership.
Hydrocodone Bitartrate, USP 7.5 mg. Ibuprofen, USP 200 mg. VICOPROFEN (hydrocodone and ibuprofen) is supplied in a fixed combination tablet form for oral administration. VICOPROFEN (hydrocodone and ibuprofen) combines the opioid analgesic agent, hydrocodone bitartrate, with the nonsteroidal anti-inflammatory (NSAID) agent, ibuprofen.
According to the United States Department of Justice Drug Enforcement Agency (DEA) and under the CSA all controlled substances are rated on a five-schedule system. Schedule V, is the lowest for the potential for abuse or dependency and I, is the highest. Xanax is a Schedule IV.ccording to the United States Department of Justice Drug Enforcement Agency (DEA) and under the CSA all controlled substances are rated on a five-schedule system. Schedule V, is the lowest for the potential for abuse or dependency and I, is the highest. Xanax is a Schedule IV.